Pyrimidine deoxyribonucleotide biosynthetic process

pathway activity — cross-omics
GO:0009221Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Pyrimidine deoxyribonucleotide biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the BRCA cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CMPK2, MX1, and OAS3, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Pyrimidine deoxyribonucleotide biosynthetic process activity versus CMPK2 in BRCA (Pearson r = 0.41).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BRCACMPK2 →+1.358+0.188<.001<.00137
BRCAMX1 →+1.424+0.171<.001.00137
HNSCOAS3 →+0.790+0.135<.001<.00136
HNSCIFIT2 →+1.571+0.176<.001<.00136
BRCAIFI44L →+1.346+0.183<.001<.00136
HNSCUSP18 →+1.168+0.120<.001<.00136
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0009221 vs CMPK2 — BRCA

Per-sample scatter of Pyrimidine deoxyribonucleotide biosynthetic process activity vs CMPK2 in BRCA.

Explore this scatter interactively →

Exploration